Argentina Sepsis Diagnostics Market Size & Outlook

The sepsis diagnostics market in Argentina is expected to reach a projected revenue of US$ 10.5 million by 2030. A compound annual growth rate of 8.2% is expected of Argentina sepsis diagnostics market from 2023 to 2030.
Revenue, 2022 (US$M)
$5.6
Forecast, 2030 (US$M)
$10.5
CAGR, 2023 - 2030
8.2%
Report Coverage
Argentina

Argentina sepsis diagnostics market, 2018-2030 (US$M)

Argentina

Argentina sepsis diagnostics market highlights

  • The Argentina sepsis diagnostics market generated a revenue of USD 5.6 million in 2022 and is expected to reach USD 10.5 million by 2030.
  • The Argentina market is expected to grow at a CAGR of 8.2% from 2023 to 2030.
  • In terms of segment, blood culture media was the largest revenue generating product in 2022.
  • Assay Kits & Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Sepsis diagnostics market data book summary

Market revenue in 2022USD 5.6 million
Market revenue in 2030USD 10.5 million
Growth rate8.2% (CAGR from 2022 to 2030)
Largest segmentBlood culture media
Fastest growing segmentAssay Kits & Reagents
Historical data2018 - 2021
Base year2022
Forecast period2023 - 2030
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Blood Culture Media, Assay Kits & Reagents, Software
Key market players worldwideBD, BioMerieux SA, Thermo Fisher Scientific Inc, Danaher Corp, Roche Holding AG ADR, Luminex, Koninklijke Philips NV, Bruker Corp, Cepheid, Immunexpress


Other key industry trends

  • In terms of revenue, Argentina accounted for 0.6% of the global sepsis diagnostics market in 2022.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Latin America, Brazil sepsis diagnostics market is projected to lead the regional market in terms of revenue in 2030.
  • Mexico is the fastest growing regional market in Latin America and is projected to reach USD 21.3 million by 2030.

Blood culture media was the largest segment with a revenue share of 39.29% in 2022. Horizon Databook has segmented the Argentina sepsis diagnostics market based on instruments, blood culture media, assay kits & reagents, software covering the revenue growth of each sub-segment from 2018 to 2030.


The rise in sepsis cases, partly attributed to the emergence of new bacterial strains, such as M1UK clones, has underscored the need for more sophisticated diagnostic technologies in Argentina.

According to a study published by the Pan-American Health Organization (PAHO) in November 2023, Argentina experienced a notable rise in reported cases and deaths from invasive group A streptococcal disease, linked to the emergence of M1UK clones and a sublineage of M1 with the toxin.

This increase has prompted PAHO/WHO to advise member states to enhance clinical & genomic surveillance and ensure prompt diagnosis and treatment of this severe condition. Socioeconomic factors influence health outcomes but are rarely considered in severe diseases. Sepsis is a common condition in low- and middle-income countries.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Sepsis Diagnostics Market Companies

Name Profile # Employees HQ Website

Argentina sepsis diagnostics market size, by product, 2018-2030 (US$M)

Argentina Sepsis Diagnostics Market Outlook Share, 2022 & 2030 (US$M)

Argentina sepsis diagnostics market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more